slides · global inventory
Testimonial
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 3,034
Current window 1,741-1,770
Pages 102
Rows per page 30
Slide type
1,741-1,770 of 3,034
116
The slide uses a Q&A format to validate the claim that the instrument is difficult to use and counter-productive to project speed.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former Employees1 hit
119
The slide uses a 'pull-quote' structure to validate the problem statement.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former Employees1 hit
120
The slide uses highlighted text to emphasize critical failure points in the expert's narrative.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former Employees1 hit
121
The slide presents two distinct quotes from an expert source regarding contamination issues.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former Employees1 hit
123
The slide uses direct quotes from an expert consultation to validate negative feedback regarding the product's usability and performance.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former Employees1 hit
142
Uses yellow highlighting to emphasize key pricing criticisms and quantitative targets.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former EmployeesLoop · Quick Win Big Bet1 hit
150
The slide uses direct quotes from former employees to validate claims of product failure.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former Employees1 hit
153
The slide uses direct quotes from former employees to validate the thesis that the product is difficult to use.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
154
The slide uses direct quotes to validate the claim of high operational burden.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
156
Uses yellow highlighting to emphasize key critical phrases within the quotes.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Expose Contradiction1 hit
160
The slide uses a pull-quote format to emphasize the lack of successful customer outcomes.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Expose Contradiction1 hit
03
The slide uses a 'villain' narrative technique by juxtaposing critical expert opinion with aggressive sales tactics and controversial industry associations.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
04
The slide uses a direct quote to frame the company's sales practices as unethical or problematic.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
44
The slide uses direct quotes from a neurologist to cast doubt on Bioprojet's professionalism and data management.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
90
The slide uses a Q&A transcript format to validate a negative thesis about the viability of H3 receptor programs.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
95
The slide uses expert testimony to establish a precedent of failure in the H3 receptor space, specifically contrasting J&J's robust trials with Bioprojet's pitolisant.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
204
The slide highlights a discrepancy between the drug's safety profile as presented and the real-world experience of a physician.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
205
The slide presents a qualitative case study (anecdotal evidence) regarding a potential adverse drug event.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
206
The slide highlights specific clinical symptoms and diagnostic procedures (EKG, cardiac enzymes, telemetry) used to rule out cardiac issues.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
207
The slide uses a Q&A format to document a specific interaction between a doctor and a pharmaceutical sales representative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
246
This slide appears to be a transition or setup slide for a quote or testimonial that is currently missing or intentionally blank.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
255
The slide uses a Q&A format to present qualitative feedback from a medical expert.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
256
The slide uses direct quotes from a physician to highlight low adoption and skepticism.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
257
Includes highlighted text emphasizing the shift in sentiment from bullish to skeptical.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
259
The slide highlights a negative expert opinion on drug efficacy, contrasting it with the prescriber's own behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
261
The slide presents qualitative feedback from a medical professional, highlighting skepticism and administrative barriers.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
262
The slide uses a Q&A format to validate the negative thesis regarding Wakix market performance.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
263
The slide uses a Q&A format to highlight the tightening reimbursement environment for a specific drug.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
30
The slide uses authority-citation to undermine the company's credibility.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Struggle to Overcome Technical Challenges1 hit
88
The slide uses direct quotes from former employees to undermine the company's claims of quantum advantage.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit